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Background: Worldwide, an estimated 2.9 million neonatal deaths occurred in 2012, accounting for 44% of all
under-five deaths. In Pakistan, more than 200,000 newborns die annually and neonatal mortality rates are higher
than in any other South Asian country and haven’t changed over the last three decades. The high number of
neonatal deaths highlights the urgent need for effective and sustainable interventions that target newborn
mortality in Pakistan.
Method/Design: This cluster randomized trial aims at evaluating the impact of delivering an integrated neonatal kit
to pregnant women during the third trimester of pregnancy and providing education on how to use the contents
(intervention arm) compared to the current standard of care (control arm) in the district of Rahimyar Khan, Punjab
province, Pakistan. The kit, which will be distributed through the national Lady Health Worker program, comprises a
clean delivery kit (sterile blade, cord clamp, clean plastic sheet, surgical gloves and hand soap), sunflower oil emollient,
chlorhexidine, ThermoSpot™, Mylar infant sleeve, and a reusable instant heat pack. Lady health workers will be
provided with a standard portable hand-held electric weighing scale. The primary outcome measure is neonatal
mortality (death in the first 28 days of life).
Discussion: While many cost-effective, evidence-based interventions to save newborn lives exist, they are not always
accessible nor have they been integrated into a portable kit designed for home-based implementation entirely by
caregivers. The implementation of cost-effective, portable, and easy-to-use interventions has tremendous potential for
sustainably reducing neonatal mortality and long-term improvements in population health. The bundling of interventions
and commodities together also has much potential for cost-effective delivery and maximizing gains from points of
contact. This study will provide empirical evidence on the feasibility and effectiveness of the delivery of an innovative
neonatal kit to pregnant women in Pakistan. Together, these findings will help inform policy on the most appropriate
interventions to improve newborn survival.
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Neonatal mortality worldwide and in Pakistan
Globally, 2.9 million newborns died in 2012 within their
first month of life, accounting for approximately 44% of
all under-five deaths [1]. While global newborn mortality
is declining, the achievements among neonates (0 –
28 days of life) are dismal compared to the reductions in
post-neonatal deaths for both infants (1-11 months of
age) and children (1 to 4 years of age).
Most neonatal deaths are largely preventable and attrib-
utable to preterm birth complications (34%), intrapartum-
related complications (25%), and infectious causes (22%)
such as sepsis, meningitis and pneumonia [2]. Notably,
many of these major causes of newborn death, namely in-
fection and hypothermia, also negatively impact develop-
ment of the growing brain. It is therefore not surprising
that more than 200 million children under 5 years, almost
all in low- and middle-income countries (LMICs), are not
reaching their developmental potential [3].
Marked disparities in neonatal mortality rates (NMRs)
exist between countries and regions. The majority of
neonatal deaths occur in low-income and middle-
income countries with the highest rates in sub-Saharan
Africa and South Asia [1,4]. Strikingly, more than half of
all newborn deaths are attributable to only five coun-
tries: India, Nigeria, Pakistan, China, and the Democratic
Republic of Congo [5].
In Pakistan, more than 200,000 newborns die annually
and in 2012, an estimated 42 newborns per every 1000 live
births died during the neonatal period [1]. Demographic
and Health Surveys collected in Pakistan between 1990 and
2012 demonstrate that neonatal mortality has increased in
every province except Khyber Pakhtunkhwa [6]. Notably, in
Punjab province neonatal mortality has increased from 58
to 63 deaths per 1000 live births [6]. In addition, within
Pakistan the risk of neonatal death is higher in rural areas
than in urban areas, in the lowest wealth quintile than in
the highest wealth quintile, and to mothers with no educa-
tion than to mothers with higher education [6]. In rural
Pakistan, most newborn deliveries occur at home with min-
imal supervision from skilled birth attendants. The problem
is further compounded by the frequent adoption of unsafe
newborn care practices including the use of unsterilized in-
struments to cut the umbilical cord, the application of un-
safe substances to the umbilical stump [7], and taboos
preventing early uptake of best practices such as feeding of
colostrum and early initiation of breastfeeding. Together,
these newborn care practices are associated with increased
risk of neonatal sepsis and mortality [8].
Primary health care infrastructure in Pakistan
The public health care delivery infrastructure in Pakistan is
three-tiered and includes primary, secondary and tertiary
care facilities [9]. Primary health care (PHC) infrastructurein Pakistan comprises over 13,000 first-level care facilities
including a network of rural health centers (RHCs), basic
health units (BHUs), dispensaries, and maternal and child
health centres (MCHC) [9]. Since over 60% of the Pakistan
population resides in rural areas [10], health care facilities
are not always accessible and thus, community-level care is
supported by trained community health workers (CHWs),
known as Lady Health Workers (LHWs). The Lady Health
Worker program was launched by the government of
Pakistan in 1994 and aims to provide PHC services to com-
munities in rural areas and urban slums [11]. Specifically,
the program targets unmet health needs in the area of ma-
ternal, newborn, child and reproductive health and provides
family planning services, and integrates with other vertical
health programs. LHWs are each affiliated with a govern-
ment health facility (BHU) and form an essential link be-
tween the formal health system and the community. LHWs
each serve a population of approximately 210 households.
LHWs are not the primary earner of their family and re-
ceive a small monetary allowance of approximately $840
USD per year. They are provided with basic medical sup-
plies that includes essential drugs for the treatment of
minor conditions such as diarrhea and acute lower respira-
tory infection (ALRI) as well as contraceptives for eligible
couples [11]. Currently, over 100,000 LHWs liaise between
the formal health system and communities to provide
antenatal care, contraceptive advice, newborn growth
monitoring, immunization services, and health education
on hygiene and sanitation [11].
Rationale and contents of integrated neonatal kit
The high neonatal mortality rates in Pakistan require ur-
gent global attention. While many proven, cost-effective
ways to save newborn lives exist, they are not always
accessible nor have they been integrated into a single
portable kit for standardized home-based caregiver-
implementation and advocacy. Such a kit consisting of
low-cost, evidence-based interventions has potential to
reduce neonatal mortality.
In this cluster-randomized controlled trial, several in-
terventions and commodities that have individually been
shown to either reduce the incidence of neonatal insults
or provide early identification of danger signs have been
integrated into a low-cost and portable neonatal kit. The
kit comprises a clean birth kit (plastic sheet, cord
clamps, sterile blade, gloves, and soap), 4% chlorhexidine
solution, sunflower oil emollient, a temperature moni-
toring device called ThermoSpot™, a Mylar infant warm-
ing blanket, and a reusable, instant heat pack that
produces heat through an exothermic crystallization re-
action of a non-toxic salt-based solution. LHWs will also
be equipped with a hand-held electric weighing scale to
identify low birth weight (LBW) newborns. Table 1 pro-
vides a detailed description of the contents (Figure 1),
Table 1 Neonatal kit components, utilization and evidence
Kit component Description Utilization Evidence
Clean birth kit (CBK) ● Contains a sterile blade to cut the umbilical cord,
clean plastic square to be placed on the ground or
other surface during birth, plastic gloves to be worn
by the birth attendant, hand soap, and cord ties/clamp
● The expectant mother will be taught
to provide the CBK to the traditional
birth attendant (TBA) or other individual
conducting the delivery
● Clean birth kits, when combined with
education, are associated with reductions
in newborn mortality and infection [12]
● Expectant mothers will be instructed
to take the CBK to health facilities where
it may be used at the discretion of the
health professional conducting the delivery
Chlorhexidine (CHX) solution ● Each kit will contain 15 mL of 4% CHX packaged
into a small plastic dispensing bottle and accompanied
by a bag of cotton balls
● Caregivers will be taught to apply a small
amount of CHX to a cotton ball and to dab
the wet cotton ball onto the umbilical stump
and surrounding area once a day from day
1 to day 10 of the newborn’s life
● CHX is a topical antiseptic that exhibits
broad-spectrum antimicrobial activity
against both Gram-positive and
Gram-negative bacterium
● Umbilical-cord cleansing with CHX
solution reduces the incidence of
omphalitis and neonatal mortality [13-16]
Sunflower oil emollient ● Each kit will contain 50 mL of sunflower oil emollient
packaged into a small plastic dispensing bottle
● Caregivers will be taught to take a small
amount of oil into their hands and massage
the oil into the newborn’s skin all over their
body once a day from day 3 until day 28 of
the newborn’s life
● In facility-based studies, sunflower oil
has been shown to protect against
hospital-acquired infections in very
low birth weight infants [17,18] and
improve survival rates in hospitalized
preterm infants [19]
Mechanically extracted from raw
sunflower seeds using an expeller
press
ThermoSpotTM ● ThermoSpotTM is a small circular device ~12 mm in
diameter that adheres to skin and allows for non-invasive,
continuous thermal monitoring [20]
● Caregivers will be taught to apply one
sticker to the axillary region of the newborn
on their first day of life and to leave the
sticker in place until it falls off on its own
or until day 14 of life (if sticker falls off it
will be replaced)
● Today, the acceptability and accuracy
of ThermoSpotTM has been
demonstrated in both hospital
[21-23] and community-based
settings [24] within developing
countries
ThermoSpotTM was obtained from
Maternova (http://maternova.net)
● ThermoSpotTM changes colour as temperature
changes [25]
● Device adheres to the skin for ~24 days [22] ● Caregivers will be taught that a bright green
face (newborn temperature 36.5°C to 37.5°C) is
normal; a blue face (temp >39.0°C) indicates
fever and care should be immediately sought
at a local health facility; a pale green and red
faces (temp 35°C to 36°C) indicate moderate
hypothermia; and, a black face (temp < 35°C)
represents severe hypothermia
● In the event of a pale green face, the caregiver
will be instructed to initiate kangaroo care (hold
the baby close to her skin), and frequently monitor
temperature
● In cases of moderate to severe hypothermia
(red and black ThermoSpot), caregivers will be
taught to place the infant in the Mylar sleeve
with warmer and immediately take the newborn




















Table 1 Neonatal kit components, utilization and evidence (Continued)
● One sterile Mylar infant sleeve will be included
in each kit
● If ThermoSpotTM indicates moderate or severe
hypothermia, caregivers will be taught to activate
the non-electric warmer and place it at the bottom
of the Mylar sleeve and then the newborn is to be
placed in the sleeve
Mylar infant sleeves were obtained
from Maternova (http://maternova.
net)
● Once the newborn is in the Mylar sleeve, the
caregiver is to immediately take the child to the
nearest health facility for further management
Reusable instant heat pack ● Instant heat packs are pocket-sized, reusable,
and placed in a fitted cloth pouch
● If ThermoSpotTM indicates moderate or severe
hypothermia, the instant heat pack will be
activated and placed, while still inside cloth
pouch, at the base of Mylar infant sleeve● Each heat pack contains a non-toxic salt-based
solution and a small metallic disc
● By flexing the metallic disc, an exothermic
crystallization reaction is triggered, which
keeps the temperature warm for ~20 to
30 minutes
Handheld battery operated
weighing scale with suspended
cloth sling
● Scale (Shenzhen Cyber Technology Ltd. Item #
CT8831) will not be included with the kit but
rather one will be issued to each LHW in the
intervention cluster
● The LHW will be instructed to weigh the newborn at
the first home visit after delivery
● The newborn will be weighed twice and the average




















Figure 1 Integrated neonatal kit contents. A) The neonatal kit includes a i) clean delivery kit, ii) 4% chlorhexidine solution that is to be applied
with iii) cotton balls, iv) sunflower oil emollient, v) ThermoSpot, vi) a reusable instant heat pack, and vii) a Mylar infant blanket. B) A handheld
battery operated weighing scale will be provided to LHWs in the intervention cluster.
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Importantly, while the efficacy of most kit components
have been validated in isolation, their combined impact re-
mains unclear. In addition, the effectiveness of several kit
components, when implemented in community-based set-
tings and delivered entirely by non-health workers remains
to be evaluated.
Hypothesis
We hypothesize that delivery of the neonatal kit to preg-
nant women during their third trimester of pregnancy
and the provision of education on how to use the indi-
vidual kit components will increase coverage rates of es-
sential interventions and reduce NMR by approximately
40% through a reduction in both infectious causes of




This study will be conducted in district Rahimyar Khan
(RYK) in Punjab province, Pakistan (Figure 2). The
country has several distinct geographical regions, includ-
ing the mountainous north and northwest, the flat plain
of river Indus in the east, and Balochistan plateau in the
west. RYK, which is located in the flat plain of river
Indus, spans a geographical area of 11,880 square
kilometers, making it the fourth largest district in Pun-
jab. Most of the country experiences extreme seasonal
variations in temperature, which range from below 0°C
during winter months and highs of 40°C during the
summer. There are 40 Union Councils in district RYK,
which are small geographical subdivisions defined for
administrative purposes. Union Councils each servebetween 20,000 to 40,000 people and typically contain a
BHU or RHC that provides basic maternal and newborn
care. Union Councils are further subdivided into smaller
geographical areas called principal villages. One or more
LHW is assigned to each principal village where they are
each responsible for the provision of PHC services to ap-
proximately 210 households.
In 2012, the estimated population of RYK was 4.5 mil-
lion people with a density of 385 individuals per square
mile. Currently, the estimated birth rate is 25 per 1000
population and approximately 55% of all births in the
district take place at home. The NMR in RYK is 42 per
1000 live births.
Study population
All pregnant women and their home- or facility-born
live births within participating clusters will be eligible
for enrollment in this study.
Study design, cluster definition and sample size
This study is designed as a cluster randomized, prag-
matic, open label controlled intervention trial that will
be conducted within the existing health care infrastruc-
ture in Pakistan. Specifically, both the intervention (neo-
natal kit) and control (standard care) will be delivered to
participants by LHWs (Figure 3). A cluster has been de-
fined as a principal village and its associated LHWs.
With an estimated live birthrate of 25 per 1000 popula-
tion, baseline NMR of 42 per 1000 live births, and a popu-
lation of ~35 live births per cluster, the randomization of
150 clusters, half to intervention and half to control, with
90% enrollment of eligible mothers and including up to a
10% loss to follow up will provide >80% power to detect a
40% reduction in mortality in the intervention compared to
Figure 2 Map of Pakistan showing the study area in District Rahimyar Khan, Punjab province.
Figure 3 Schematic diagram of trial activities.
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ceive the same intervention. Since clusters are geographic-
ally separated from one another and families within each
cluster are typically non-mobile, contamination is unlikely
but to further avoid contamination, unused kit components
will be collected from participants during their last data
collection visit (day 28 of newborn’s life). Unused kit com-
ponents will be also be collected in cases of stillbirths and
child death after enrollment.
Randomization
Randomization will be performed on principal villages
(clusters) stratified into two groups before randomization:
villages with 1 LHW and those with more than 1 LHW.
To balance cluster size, one large village will be ex-
cluded and the remaining villages will be randomized
into two groups (intervention and control). To ensure
that randomization is unbiased, a scientist who is not
directly involved in the research project will perform
the cluster-stratified randomization.
Delivery of the integrated neonatal kit
To facilitate future scale-up efforts, the delivery of the
neonatal kit will be built into the existing schedule of
LHW home visits. As part of the current program,
LHWs routinely visit pregnant women during their third
trimester of pregnancy. During the third trimester visit,
following a study worker obtaining consent, LHWs will
leave the kit with all enrolled pregnant women in
Table 2 Primary and secondary outcome measures
Outcome Definition
Primary outcome
All-cause neonatal mortality Death from any cause in the first 28 days
of life
Secondary outcomes
Incidence of omphalitis A) None (no redness or swelling);
B) Mild (inflammation limited to the
cord stump);
C) Moderate (inflammation extending to
the skin at the base of the cord stump
less than 2 cm); or
D) Severe (inflammation extending more
than 2 cm from the cord stump)
Incidence of severe infection A) Convulsions; or
B) Fast breathing (60 breaths per minute
or more); or
C) Severe chest indrawing; or
D) Movement only when stimulated or
no movement at all; or
E) Not feeding at all for at least 12 hours
Cases of hypothermia and
hyperthermia identified
Defined using ThermoSpot:
A) Moderate hypothermia: pale green
and red face (35°C to 36°C)
B) Severe hypothermia: black face (<35°C)
C) Hyperthermia: blue face (>39°C)
Number of LBW newborns
identified
<2500 grams at first weighing
Health facility use Health centre visits to
A) Dispensary
B) Basic Health Unit (BHU)
C) Rural Health Centre (RHC)
D) Tehsil Head Quarter (THQ)




12 months of age
Defined by the neurodevelopment score
assigned at 12 months of age as
measured by the standardized Bayley
Scales of Infant Development III
assessment tool
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properly use the components of the kit. There will not
be any additional health education component beyond
that pertaining to the use of the kit contents. In order to
optimize data collection in the critical period immedi-
ately following delivery, a small incentive will be pro-
vided to the first person that notifies the study team of a
birth within 24 hours of delivery. To facilitate birth noti-
fications, LHWs, community leaders, and the family of
expectant women will be provided with an information
card outlining instructions to call a specific phone num-
ber within 24 hours of delivery. The phone call will be
directed to a study research officer who will maintain a
daily call log and disburse the incentive to the first party
who provided birth notification. In the existing LHW
program, LHWs are meant to visit all births within
24 hours of delivery and thus, at this post-delivery visit,
LHWs will reiterate their teachings regarding the correct
use of the neonatal kit contents.
Study outcome measures
The primary outcome in this study is all-cause neonatal
mortality. Secondary outcomes include the incidence of
omphalitis, severe infection, identified cases of hypothermia
and hyperthermia, number of LBW newborns identified,
health facility usage, and neurodevelopment measured at
12 months of age (Table 2). Due to the nature of the inter-
vention, blinding is not possible, however to reduce meas-
urement bias, outcome data will be collected by an
independent team that will not be involved in the delivery
of the intervention.
Contents and utilization of the neonatal kit
The integrated neonatal kit comprises a clean birth kit,
4% chlorhexidine solution, sunflower oil emollient, Ther-
moSpot™, Mylar infant sleeve, and a reusable, instant
heat pack (Figure 1A). In addition, LHWs will be sup-
plied with a handheld electric weighing scale (Figure 1B)
with suspended cloth sling to weigh newborns. A de-
tailed description of each kit component, its intended
utilization and associated evidence is outlined in Table 1.
Clean birth kit
Expectant mothers will be taught to provide the clean
birth kit to the traditional birth attendant (TBA) or
other individual conducting the delivery. If the expectant
mother will be delivering her baby in a health facility,
she will be instructed to take the clean birth kit to the
facility where it may be used at the discretion of the
health professional conducting the delivery.
Chlorhexidine solution (4%)
Caregivers will be taught to apply a small amount of 4%
chlorhexidine to a cotton ball and to dab the wet cottonball onto the umbilical stump and surrounding area once
a day from day 1 to day 10 of the newborn’s life.
Sunflower oil emollient
The caregiver will be taught to take a small amount of
oil into their hands and massage the oil into the new-
born’s skin all over their body once a day from day 3
until day 28 of the newborn’s life. In this study, sun-
flower oil was mechanically extracted from raw sun-
flower seeds using an expeller press.
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ThermoSpot™ is a small circular sticker that adheres to
the skin and changes colour as temperature changes
[25], allowing for continuous temperature monitoring.
Five ThermoSpot™ stickers will be provided in each kit.
Caregivers will be taught to apply one sticker to the axil-
lary region of the newborn on their first day of life and
to leave the sticker in place until it falls off on its own or
until day 14 of life. If a sticker falls off, it will be replaced
with a new one. The meaning of the appearance of each
ThermoSpot™ will be explained to caregivers as well as
the measures to be taken if the device indicates any sign
of fever or hypothermia.
Mylar infant sleeve
The caregiver will be taught that if ThermoSpot™ indi-
cates moderate or severe hypothermia (Table 1), the
non-electric warmer is to be activated and placed at the
bottom of the Mylar sleeve and then the newborn is to be
placed in the sleeve. Once the newborn is in the Mylar
sleeve, the caregiver is to immediately take the child to the
nearest health facility for further management.
Reusable instant heat pack
If ThermoSpot™ indicates moderate or severe hypothermia,
caregivers will be taught to activate the FDA-approved
reusable instant heat pack and place it first inside a cloth
pouch, and then at the base of Mylar infant sleeve. The ac-
tivated heat pack holds its temperature for approximately
20 to 30 minutes.
Handheld battery-operated weighing scale with suspended
cloth sling
The scale will not be included with the kit but rather,
one will be issued to each LHW in the intervention clus-
ter. The LHW will be instructed to weigh the newborn
at the first home visit after delivery. The newborn will
be weighed twice and the average of these two weights
will be recorded as the birth weight.
Data collection and data management
Data collectors will be independent from LHWs and will
be selected based on their high level of performance in
previous work at the same study site. All data collectors
will undergo three days of formal training where they
will be taught the goals of the study, basic methodology,
and provided with an in-depth understanding of all data
collection forms. During training, data collectors will
be required to conduct an observed interaction with a
mother and newborn in the community to ensure
standardization and quality data collection.
Data collectors will visit homes in the intervention and
control clusters on day 1 (or as soon as possible after
birth notification), 3, 7, 14, and 28 of life. To facilitatebirth notifications, LHWs, community leaders, and the
family of expectant women will be provided with in-
structions to call a study research officer within 24 hours
of delivery. The research officer will notify the appropri-
ate data collector. At the first visit, the data collector will
administer a questionnaire to document the events sur-
rounding delivery and the immediate post-natal status of
the newborn and weigh the newborn. At each subse-
quent visit, the data collector will assess the newborn for
primary and secondary outcomes through the adminis-
tration of a questionnaire covering the events that took
place since the last visit. Data collectors will be trained
to identify danger signs and will refer the newborn to
the LHW, triggering the appropriate cascade of events
leading to referral to the most appropriate health facility.
Data collectors will not be trained to treat outcome con-
ditions. At any of these visits, the data collectors may be
notified of the death of a baby. In the event of a new-
born death, the parent will be given the choice of
whether or not a verbal autopsy [26] can be performed.
At 12 months of age, a proportion (approximately 450)
of randomly selected children from each arm of the
study will undergo a standardized assessment of neuro-
development by a study worker trained in the applica-
tion of the Bayley Scale of Infant Development III
(BSIDIII) [27]. The data collector will be blinded to the
arm of the trial to which the participant was randomized.
The assessment takes up to 1 hour to administer, will be
conducted in the homes of participants, and will be per-
formed in the presence of a parent or caregiver. During the
BSID standardized test, five key developmental domains of
cognition, language, social-emotional, and motor and adap-
tive behaviour of the child are assessed [27].
Paper data collection forms will be delivered to the
data management unit (DMU) on a daily basis where
they will be entered in duplicate into electronic format.
Prior to data entry, all forms will be checked for
completeness and consistency and coded. In cases of
inconsistency or missing responses, editors will flag the
errors/omissions and consult data collectors for possible
explanations. Research officers and supervisors will val-
idate 5% and 2% respectively, of all home visits by recol-
lecting data and comparing data collection forms with
those filled in by data collectors. In cases where discrep-
ancies exceed 20%, data collectors will be retrained. Da-
tabases will be developed using Microsoft FoxPro and
will employ a range of consistency checks to minimize
data entry errors.
Data analysis plan
The primary outcome (death during the neonatal period)
will be measured in both the intervention and control
arms on days 1, 3, 7, 14, and 28 of a newborn’s life. This
trial’s data will be analyzed as intention to treat using
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be adjusted for cluster allocation via generalized estimat-
ing equations using a log link between the binary
response variable (binomial family) and the linear pre-
dictor, and unstructured correlations between observa-
tions. STATA version 13 will be used for all data
analyses. Causes of death will be determined by phys-
ician review of verbal autopsy. Results will be presented
in accordance with CONSORT guidelines.
Ethical considerations
This study has gained ethical approval from the National
Bioethics Committee of the Government of Pakistan,
and the Research Ethics Board at The Hospital for Sick
Children, Toronto, Canada.
Discussion
Today, 44% of all under-five deaths occur in the neo-
natal period (within the first 28 days of life) [1] and pro-
gress in newborn survival lags behind the achievements
made in maternal and child mortality. For example,
while the number of global neonatal deaths has de-
creased from an estimated 4.6 million in 1990 to 2.9 mil-
lion in 2012, the number of newborn deaths as a
proportion of overall child mortality has increased dur-
ing this same time period from 37% to 44% [1]. Without
increased global action, it is estimated that by 2035 there
will be an additional 49 million neonatal deaths [5].
More than half of all neonatal deaths occur in only five
countries: India, Nigeria, Pakistan, China, Democratic
Republic of Congo [5]. In Pakistan, more than 200,000
newborns die each year and the NMRs are among the
highest in the world [1]. In rural Pakistan, most newborns
are delivered at home and receive minimal monitoring
from skilled health care professionals. Compounding these
sub-optimal conditions, unsafe newborn care practices,
which are associated with increased risk of neonatal sepsis
and mortality [8], are commonly practiced behaviors in the
region [7].
While evidence exists in support of various health in-
terventions for reducing neonatal mortality, these inter-
ventions are not always accessible or affordable to those
who need them most. In resource poor, rural settings,
many births occur at home without supervision from
medically trained personnel. In these settings, a multi-
tude of interconnected factors such as geography, infra-
structure, and poverty act as barriers to high-quality
health care. Transformations to the Pakistan health sys-
tem, including the introduction of the LHW program,
place the country in an ideal position to improve popu-
lation health coverage and decrease neonatal mortality.
The LHW program aims to achieve universal health
coverage through the provision of PHC care services in
rural communities and urban slums. Indeed, knowledgeof LHWs among women in rural communities is high.
In Punjab province, 84.4% of married women between
the ages of 15-49 living in a rural area know about the
presence of LHWs in their area, compared to 65.9% in
urban areas [6]. Evidence suggests that the empower-
ment of local community workers in the delivery of
health interventions and home-based care leads to a dra-
matic increase in child survival [28].
In this study, a portable, low-cost, integrated kit com-
prised of evidence-based interventions will be delivered
to pregnant women in RYK, Pakistan through the exist-
ing LHW infrastructure. The delivery of the intervention
through the LHW program, combined with educating
caregivers on how to use the neonatal kit contents will
facilitate long-term sustainability. The findings of this
trial will provide empirical evidence to inform policy on
the implementation of sustainable interventions in rural
settings to improve neonatal mortality in Pakistan.
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